Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen

Journal of Clinical Oncology

Volumn 14, Issue 3, 1996, Pages 925-934

  Magrath, I ^a   Adde, M ^a   Shad, A ^a   Venzon, D ^a   Seibel, N ^a   Gootenberg, J ^a   Neely, J ^a   Arndt, C ^a   Nieder, M ^a   Jaffe, E ^a   Wittes, R A ^a   Horak, I D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IFOSFAMIDE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CHILD; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 9044226138     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.3.925     Document Type: Article

References (26)

1. Philip T, Pinkerton R, Biron P, et al: Effective multiagent chemotherapy in children with advanced B-cell lymphoma: Who remains the high risk patient? Br J Haematol 65:159-164, 1987
2. Schwenn M, Blattner SR, Lynch E, et al: HiC-COM: A 2 month intensive chemotherapy regimen for children with stage III and IV Burkitt's lymphoma and B-cell acute lymphoblastic leukemia. J Clin Oncol 9:133-138, 1991
3. Patte C, Philip T, Rodary C, et al: High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: Results from the French Pediatric Oncology Society of a randomized trial of 216 children. J Clin Oncol 9:123-132, 1991
4. Reiter A, Schrappe M, Ludwig W-D, et al: Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: A report of three consecutive studies of the BFM group. Blood 80:2471-2478, 1992
5. Reiter A, Schrappe M, Parwaresch R, et al: Non-Hodgkin's lymphomas of childhood and adolescence: Results of a treatment stratified for biological subtypes and stage. A report of the Berlin-Frankfurt-Münster group. J Clin Oncol 13:359-372, 1995
6. Coiffier B, Bryon P-A, Ffrench M, et al: Intensive chemotherapy in aggressive lymphomas: Updated results of LNH-80 protocol and prognostic factors affecting response and survival. Blood 70:1394-1399, 1987
7. Lopez TM, Hagemeister FB, McLaughlin P, et al: Small non-cleaved cell lymphoma in adults: Superior results for stages I-III. J Clin Oncol 8:615-622, 1990
8. McMaster ML, Greer JP, Greco A, et al: Effective treatment of small non-cleaved-cell lymphomas with high-intensity, brief-duration chemotherapy. J Clin Oncol 9:941-946, 1991
9. Longo DL, Duffey PL, Jaffe ES, et al: Diffuse small non-cleaved cell, non-Burkitt's lymphoma in adults: A high-grade lymphoma responsive to ProMACE-based combination chemotherapy. J Clin Oncol 12:2135-2159, 1994
10. Soussain C, Patte C, Ostronoff M, et al: Small noncleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols. Blood 85:664-674, 1995
11. Fifth International Workshop on Chromosomes in Leukemia and Lymphoma. Blood 70:1554-64, 1987
12. Yano T, Van Krieken J, Magrath I, et al: Histogenetic correlations between subcategories of small non-cleaved cell lymphomas. Blood 79:1282-1290, 1992
13. Magrath IT, Janus C, Edwards BK, et al: An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults. Blood 63:1102-1111, 1984
14. Berstein JI, Coleman CN, Strickler JG, et al: Combined modality therapy for adults with small non-cleaved cell lymphoma (Burkitt's and non-Burkitt's types). J Clin Oncol 4:847-858, 1988
15. 14a. Weintraub M, Adde MA, Venzon DJ, et al: Severe atypical neuropathy associated with administration of hematopoietic colony-stimulating factors and vincristine. J Clin Oncol 14:935-940, 1996
16. 2 therapy for childhood non-Hodgkin's lymphoma: A report of CCG-551 from the Childrens Cancer Group. J Clin Oncol 11:1024-1032, 1993
17. Magrath IT, Adde MA, Sandlund J, et al: Ifosfamide in the treatment of high grade recurrent non-Hodgkin's lymphomas. Hematol Oncol 9:267-274, 1991
18. Gentet JC, Patte C, Quintana E, et al: Phase II study of cytarabine and etoposide in children with refractory or relapsed non-Hodgkin's lymphoma: A study of the French Society of Pediatric Oncology. J Clin Oncol 8:661-665, 1990
19. Murphy S, Bowman W, Abromowitch M, et al: Results of treatment of advanced stage Burkitt's lymphoma and B-cell, (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. J Clin Oncol 4:1732-1739, 1986
20. Gasparini M, Rottoli L, Massimino M, et al: Curability of advanced Burkitt's lymphoma in children by intensive short-term chemotherapy. Eur J Cancer 29A:692-698, 1993
21. Fisher RI, Gaynor ER, Dahlberg S, et al: Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. New Engl J Med 328:1002-1006, 1993
22. Sigaux F, Berger R, Bernheim A, et al: Malignant lymphomas with band 8q24 chromosome abnormality: A morphological continuum extending from Burkitt's to immunoblastic lymphoma. Br J Haematol 57:393-405, 1984
23. Harris N, Jaffe E, Stein H, et al: A proposal for an international consensus on the classification of lymphoid neoplasms. Blood 84:1361-1392, 1994
24. Bloomfield CD, Arthur DC, Frizzera G, et al: Nonrandom chromosome abnormalities in lymphoma. Cancer Res 43:2975-2984, 1983
25. Bastard C, Deweindt C, Kerckaert JP, et al: LAZ3 rearrangements in non-Hodgkin's lymphoma: Correlation with histology, immunophenotype, karyotype and clinical outcome in 217 patients. Blood 83:2423-2437, 1994
26. Offit K, Lo Coco F, Louie DC, et al: Rerrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma. N Engl J Med 331:74-80, 1994